image
Healthcare - Medical - Healthcare Plans - NASDAQ - US
$ 17.82
-1.6 %
$ 3.42 B
Market Cap
-26.6
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ALHC stock under the worst case scenario is HIDDEN Compared to the current market price of 17.8 USD, Alignment Healthcare, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ALHC stock under the base case scenario is HIDDEN Compared to the current market price of 17.8 USD, Alignment Healthcare, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ALHC stock under the best case scenario is HIDDEN Compared to the current market price of 17.8 USD, Alignment Healthcare, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ALHC

image
$19.0$19.0$18.0$18.0$17.0$17.0$16.0$16.0$15.0$15.0$14.0$14.0$13.0$13.0$12.0$12.0$11.0$11.0$10.0$10.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
2.7 B REVENUE
48.25%
-102 M OPERATING INCOME
20.55%
-128 M NET INCOME
13.57%
34.8 M OPERATING CASH FLOW
158.75%
39.2 M INVESTING CASH FLOW
126.61%
156 M FINANCING CASH FLOW
148498.10%
701 M REVENUE
1.27%
-22.5 M OPERATING INCOME
-15.49%
-31.1 M NET INCOME
-17.54%
-8.71 M OPERATING CASH FLOW
-33.26%
-5.92 M INVESTING CASH FLOW
75.90%
107 M FINANCING CASH FLOW
712400.00%
Balance Sheet Alignment Healthcare, Inc.
image
Current Assets 662 M
Cash & Short-Term Investments 471 M
Receivables 154 M
Other Current Assets 37.1 M
Non-Current Assets 120 M
Long-Term Investments 0
PP&E 75 M
Other Non-Current Assets 45.5 M
60.18 %19.68 %4.74 %9.58 %5.81 %Total Assets$782.1m
Current Liabilities 352 M
Accounts Payable 242 M
Short-Term Debt 0
Other Current Liabilities 109 M
Non-Current Liabilities 329 M
Long-Term Debt 15.7 M
Other Non-Current Liabilities 314 M
35.60 %16.05 %46.04 %Total Liabilities$681.1m
EFFICIENCY
Earnings Waterfall Alignment Healthcare, Inc.
image
Revenue 2.7 B
Cost Of Revenue 2.41 B
Gross Profit 297 M
Operating Expenses 398 M
Operating Income -102 M
Other Expenses 26.5 M
Net Income -128 M
3b3b3b3b2b2b2b2b1b1b500m500m00(500m)(500m)3b(2b)297m(398m)(102m)(27m)(128m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
10.97% GROSS MARGIN
10.97%
-3.76% OPERATING MARGIN
-3.76%
-4.74% NET MARGIN
-4.74%
-128.23% ROE
-128.23%
-16.37% ROA
-16.37%
-23.61% ROIC
-23.61%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Alignment Healthcare, Inc.
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)(80m)(80m)(90m)(90m)(100m)(100m)202020202021202120222022202320232024202420252025
Net Income -128 M
Depreciation & Amortization 27.1 M
Capital Expenditures -41.4 M
Stock-Based Compensation 71.1 M
Change in Working Capital 60.9 M
Others 100 M
Free Cash Flow -6.65 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Alignment Healthcare, Inc.
image
Wall Street analysts predict an average 1-year price target for ALHC of $11.3 , with forecasts ranging from a low of $7 to a high of $21 .
ALHC Lowest Price Target Wall Street Target
7 USD -60.72%
ALHC Average Price Target Wall Street Target
11.3 USD -36.40%
ALHC Highest Price Target Wall Street Target
21 USD 17.85%
Price
Max Price Target
Min Price Target
Average Price Target
2222202018181616141412121010886644May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 8
6. Ownership
Insider Ownership Alignment Healthcare, Inc.
image
Sold
0-3 MONTHS
36.7 M USD 9
3-6 MONTHS
6.24 M USD 7
6-9 MONTHS
10.2 M USD 8
9-12 MONTHS
307 K USD 3
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Alignment Healthcare, Inc. (ALHC) Q4 2024 Earnings Call Transcript Alignment Healthcare, Inc. (NASDAQ:ALHC ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants John Kao - Founder & Chief Executive Officer Thomas Freeman - Chief Financial Officer Conference Call Participants Scott Fidel - Stephens Adam Ron - Bank of America Michael Ha - Baird Matthew Gillmor - KeyBanc Capital Markets Jessica Tassan - Piper Sandler Operator Good afternoon, and welcome to Alignment Healthcare's Fourth Quarter 2024 Earnings Conference Call and Webcast. [Operator Instructions]. seekingalpha.com - 1 month ago
Alignment Healthcare to Present at the Leerink Global Healthcare Conference and KeyBanc Capital Markets Healthcare Forum ORANGE, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the following conferences: globenewswire.com - 1 month ago
Compared to Estimates, Alignment Healthcare (ALHC) Q4 Earnings: A Look at Key Metrics The headline numbers for Alignment Healthcare (ALHC) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com - 1 month ago
Alignment Healthcare (ALHC) Reports Q4 Loss, Tops Revenue Estimates Alignment Healthcare (ALHC) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.25 per share a year ago. zacks.com - 1 month ago
Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance ORANGE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its fourth quarter and full year ended Dec. 31, 2024. globenewswire.com - 1 month ago
Insights Into Alignment Healthcare (ALHC) Q4: Wall Street Projections for Key Metrics Get a deeper insight into the potential performance of Alignment Healthcare (ALHC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. zacks.com - 1 month ago
Alignment Healthcare to Announce Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call Thursday, Feb. 27, 2025 ORANGE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its fourth quarter and full-year 2024 financial results on Thursday, Feb. 27, 2025, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EST. globenewswire.com - 2 months ago
Focus On Costs, Regulatory Outlook For Health Insurers In Q4'24 Earnings Season Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-side analyst forecasts. Coming off a challenging end to 2024, the upcoming earnings season is an opportunity for managed care companies to focus on 2025 expectations and Medicare Advantage growth, according to J.P. Morgan analyst Lisa Gill. UnitedHealth and Oscar Health are expected to log sequential and year-over-year revenue growth. seekingalpha.com - 2 months ago
Alignment Healthcare Announces Industry-Leading Membership Growth and Promotion of Dawn Maroney to President ORANGE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), an award-winning Medicare Advantage (MA) company, today announced Jan. 1 health plan membership of approximately 209,900, representing a 35% year-over-year increase in health plan membership when compared to membership as of Jan. 1, 2024. Additionally, the company expects to have 225,000 to 231,000 health plan members as of Dec. 31, 2025, representing growth of approximately 22% to 25% relative to the midpoint of its year-end 2024 membership guidance provided on Oct. 29, 2024. globenewswire.com - 2 months ago
UPDATE – Alignment Healthcare to Present at the 43rd Annual J.P. Morgan Healthcare Conference ORANGE, Calif. , Dec. 30, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15, at 11:15 a.m. PST. globenewswire.com - 3 months ago
Alignment Healthcare to Present at the 43rd Annual J.P. Morgan Healthcare Conference ORANGE, Calif. , Dec. 20, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15, at 1:30 p.m. PST. globenewswire.com - 3 months ago
Alignment Health Plan Expands Access to Care in Arizona through Enhanced Agreement with Arizona Priority Care Agreement expansion offers Alignment members access to all Banner Health hospitals and specialists in Arizona Agreement expansion offers Alignment members access to all Banner Health hospitals and specialists in Arizona globenewswire.com - 4 months ago
8. Profile Summary

Alignment Healthcare, Inc. ALHC

image
COUNTRY US
INDUSTRY Medical - Healthcare Plans
MARKET CAP $ 3.42 B
Dividend Yield 0.00%
Description Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
Contact 1100 West Town and Country Road, Orange, CA, 92868 https://www.alignmenthealthcare.com
IPO Date March 26, 2021
Employees 1679
Officers Mr. Hakan Kardes Chief Experience Officer Mr. Robert L. Scavo Chief Information Officer Ms. Dawn Christine Maroney President Mr. John E. Kao Founder, Chief Executive Officer & Director Mr. Christopher J. Joyce J.D. Chief Legal & Administrative Officer Mr. Robert Thomas Freeman Chief Financial Officer Ms. Charlotte LeBlanc Chief Accounting Officer & Senior Vice President Dr. Hyong J. Kim M.D. Chief Medical Officer Dr. Donald S. Furman M.B.A., M.D. Co-Founder & Chief Clinical Officer Mr. Andreas Wagner Chief Human Resources Officer